Analysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF) and Fate Therapeutics (FATE)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Fate ...
Nkarta (NKTX) Gets a Buy from Leerink Partners
Leerink Partners analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) yesterday and set a price target of $7.00.
Hosted on MSN11mon
Why Nkarta Stock Just Boomeranged Following A Massive Dive On Friday
One patients showed normal B cells after a year. Leerink Partners analyst Daina Graybosch says the results prove the benefit for NKX019, which the company is also testing in patients with lupus ...